Article History
Accepted: 17 December 2021
First Online: 24 January 2022
Change Date: 23 October 2022
Change Type: Update
Change Details: Springer Nature’s version of this paper was updated to structure the references accordingly.
Change Date: 10 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40140-022-00546-w
Declarations
:
: Alexander Y. Mitrophanov declares that he has no conflict of interest. Kofi Vandyck declares that he has no conflict of interest. Kenichi A. Tanaka has served on an advisory board for Octapharma relating to the clinical study of prothrombin complex concentrate, but did not receive any input from the company relating to the preparation of this manuscript.
: This article does not contain any studies with human or animal subjects performed by any authors.